Head-to-head · WeighScore
Dr. Arevitalize vs MyStart Health
By GLP-1 ScorecardUpdated
Score comparison
Dr. Arevitalize has the higher recorded score — 65.2/100 to 61.3/100.
Dr. Arevitalize grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Dr. Arevitalize (Dr.Arevitalize Health, Inc.) is a LegitScript-certified telehealth platform offering compounded GLP-1 weight-loss medication in both injectable and oral-capsule forms — semaglutide from $269/mo and tirzepatide from $349/mo, sold in 1-, 3-, 6-, and 12-month bundles.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Dr. Arevitalize | MyStart Health |
|---|---|---|
| WeighScore | 65.2/100 | 61.3/100 |
| Grade | C | C |
| Site position | #250 | #337 |
| Semaglutide | $319/mo (compounded) | $299/mo (all doses, compounded) |
| Tirzepatide | $359/mo (compounded) | $299/mo (all doses, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #250 · C
Strengths
- Offers both injectable and oral-capsule compounded GLP-1 — a needle-free option many providers do not carry
- Semaglutide from $269/mo and tirzepatide from $349/mo, in 1-, 3-, 6-, and 12-month bundles
- LegitScript-certified; clinician-guided with lab/bloodwork analysis and personalized plans
- Intro pricing on injectable semaglutide ($269, was $319) and oral semaglutide ($299, was $349)
What to consider
- Compounded GLP-1s are not FDA-approved finished products
- Compounding pharmacy partner and prescribing clinician are not named on the site
- State availability is not published on the site
Site position #337 · C
FDAWarning letter issued to Matthew Stern, CEO MyStart Health LLC. in September 2025. See the FDA warning-letter database.
Strengths
- Price Lock Guarantee — your $299 base rate doesn't rise as your dose escalates
- Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
- 24/7 care team access with unlimited clinician messaging included
- LegitScript certified
- Clear Section 503A compounding disclosure on every landing page
What to consider
- Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
- Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- Markets oral tirzepatide, but no FDA-approved oral tirzepatide exists
- Very new company (incorporated May 2024) with a limited track record
- FDA issued Matthew Stern, CEO MyStart Health LLC. a warning letter in September 2025; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.